LeMaitre Vascular Bundle
Who owns LeMaitre Vascular today?
LeMaitre Vascular, founded by Dr. George D. LeMaitre in 1983 and public since 2006, designs specialty devices for vascular surgeons and sells globally from Burlington, MA.
Institutional investors hold the bulk of LeMaitre Vascular (NASDAQ: LMAT) shares, with founders and insiders retaining meaningful positions; revenue in 2024–2025 was about $180–$200 million and market cap typically ranges near $2.0–$3.0 billion.
Explore a product analysis: LeMaitre Vascular Porter's Five Forces Analysis
Who Founded LeMaitre Vascular?
LeMaitre Vascular was founded by Dr. George D. LeMaitre, a practicing vascular surgeon, who retained controlling ownership while commercializing the LeMaitre valvulotome; his son George W. 'Will' LeMaitre joined early, helped scale operations, and later became CEO, preserving clinical-led governance.
Founder background
Dr. George D. LeMaitre invented the valvulotome while practicing vascular surgery and spun out the company to commercialize the device.
Early family ownership
Initial equity was concentrated in the LeMaitre family, with common stock and option pools aligned to retain long-term control.
Role of George W. LeMaitre
George W. 'Will' LeMaitre joined in an operational role, later becoming CEO and professionalizing the company's commercial strategy.
Friends-and-family investors
Early clinician supporters and close associates held limited stakes, typical of surgeon-founded device firms in the 1980s–1990s.
Standard founder protections
Founders used vesting, right-of-first-refusal, and buy-sell provisions to preserve strategic control before institutional financing and IPO.
Pre-IPO ownership concentration
SEC filings and corporate records indicate the LeMaitre family held a majority stake prior to institutionalization and the public offering.
Early governance reflected a clinical-first vision and conservative capital strategy, with no widely reported founder disputes and continuity guided by family-led ownership and governance documents.
Key facts and implications
Founders and early ownership shaped LeMaitre Vascular's trajectory from invention to IPO; relevant for understanding current LeMaitre Vascular ownership and shareholder dynamics.
- Founder: Dr. George D. LeMaitre; early majority holder
- Early CEO and scaler: George W. 'Will' LeMaitre
- Pre-IPO structure: family majority plus friends-and-family investors
- Governance tools: vesting, ROFR, buy-sell provisions to maintain control
For historical context on strategy, see the article Marketing Strategy of LeMaitre Vascular which complements ownership history and sheds light on commercialization choices that influenced early shareholder composition.
LeMaitre Vascular SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has LeMaitre Vascular’s Ownership Changed Over Time?
Key inflection points that reshaped LeMaitre Vascular ownership include professionalization in the late 1990s/early 2000s and the October 2006 NASDAQ IPO (ticker LMAT), which converted a family-centric cap table into a public float and funded international expansion and tuck-in acquisitions.
| Period | Ownership Shift | Impact |
|---|---|---|
| Pre-2000s | Family/insider control | Founder-led strategic direction and concentrated voting |
| Late 1990s–2006 | Professionalization; governance upgrades | Prepared company for IPO and institutional scrutiny |
| 2006 IPO | Public listing under LMAT; capital raise | $Initial market cap in low hundreds of millions; funded international growth and acquisitions |
| 2024–2025 | Institutional indexation and diversified holder base | Market cap commonly around $2–3 billion; >90% of public float held by institutions |
Current cap table reflects mid-cap U.S. medtech norms: LeMaitre family/insiders retain a meaningful stake (mid- to high-single digits of outstanding shares), large passive managers (Vanguard, BlackRock, State Street) plus healthcare active funds hold the bulk of shares, and retail represents a smaller dividend-sensitive tranche.
Ownership Evolution and Major Stakeholders
Ownership moved from founder-dominated to institutionally held as LMAT matured; index inclusion and strong operating performance drove passive inflows and higher liquidity.
- Founders/insiders: LeMaitre family, led by CEO George W. LeMaitre — mid- to high-single digit ownership percentage
- Institutions/index funds: Vanguard, BlackRock, State Street among largest holders; institutional ownership typically >90% of public float
- Retail/public float: Smaller portion, attracted by steady profitability and dividend history
- Ownership dynamics: Passive stakes rose with indexation; active healthcare managers adjust around product cycles and M&A
For deeper strategic context and how acquisitions influenced ownership and growth, see the article Growth Strategy of LeMaitre Vascular.
LeMaitre Vascular PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on LeMaitre Vascular’s Board?
LeMaitre Vascular's board combines founder leadership and independent oversight under a one-share-one-vote public structure. George W. LeMaitre serves as Chairman and CEO alongside a majority-independent board with clinical, regulatory, medtech operating and financial expertise.
| Director | Role / Expertise | Committee Chairs |
|---|---|---|
| George W. LeMaitre | Chairman & CEO — founder/insider, long-term strategy | Executive |
| Independent Director A | Former device executive — commercial & operations | Nominating/Governance |
| Independent Director B | Clinical/regulatory leader — medtech compliance | Compensation |
| Independent Director C | Finance leader — accounting, audit oversight | Audit |
The company has no dual-class shares, golden shares, or disclosed special founder voting rights; voting power is proportional to common stock ownership and routine proxy voting by institutions.
Board composition and voting dynamics
Board control reflects ordinary ownership and leadership roles, with institutional investors collectively exerting significant influence through proxy voting.
- LeMaitre Vascular ownership follows a one-share-one-vote model without special voting classes
- Major institutional holders (index funds, mutual funds) account for the largest pooled voting blocs—typically over 50% of free‑float voting power in similar small-cap medtechs
- Shareholder proposals through 2024–2025 focused on compensation alignment, board refreshment, and ESG disclosures
- For historical context see the company overview: Brief History of LeMaitre Vascular
LeMaitre Vascular Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped LeMaitre Vascular’s Ownership Landscape?
Since 2019 LeMaitre Vascular's ownership has trended toward greater institutional concentration as market cap growth and index inclusion increased passive fund stakes, while steady tuck‑in M&A, dividends and modest equity issuance slightly changed the share count without major ownership shifts.
| Trend | Evidence (2019–2025) | Impact on Ownership |
|---|---|---|
| Rising institutional/passive ownership | Index inclusion and market cap expansion saw Vanguard, BlackRock and State Street stakes rise to institutional block holdings exceeding typical retail levels by 2024–2025 | Concentration of voting power; longer holding periods and lower turnover |
| Tuck‑in M&A funded from operations | Multiple small acquisitions funded largely from operating cash flow and modest debt; accretive to revenue and margins | Incremental equity issuance modestly diluted shareholders but supported growth |
| Dividend policy and payouts | Regular quarterly dividends with occasional increases through 2024–2025 | Attracted income‑oriented funds and reinforced institutional long‑term holdings |
| Insider transactions | Periodic executive/director sales for diversification and option exercises; founders and management retain meaningful stakes | Limited insider drift; alignment with long‑term value creation |
| Share count dynamics | Moderate change from employee equity programs and M&A; no dominant buyback program as of 2025 | Capital return mix favors dividends over large buybacks |
Analysts expect continued institutional concentration of LeMaitre Vascular ownership absent a step‑change transaction; potential future shifts include larger strategic acquisitions, index rebalances or sector consolidation in vascular surgery devices, while the company remains a publicly traded, founder‑led consolidator.
Institutional concentration
By 2025 passive ETFs and large asset managers held a substantially larger share versus 2019, increasing the influence of index rebalances on Who owns LeMaitre Vascular decisions.
M&A and share dilution
Small, accretive tuck‑ins funded from operating cash and modest leverage caused only modest equity dilution while supporting margin expansion and revenue growth.
Dividend appeal
Regular dividends and occasional increases through 2024–2025 helped attract income‑oriented LeMaitre Vascular shareholders and lengthen institutional holding periods.
Insider alignment
Despite periodic insider sales for diversification, founder and executive ownership remained material, supporting governance continuity and strategic execution.
For detailed governance and values tied to ownership and leadership, see Mission, Vision & Core Values of LeMaitre Vascular
LeMaitre Vascular Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of LeMaitre Vascular Company?
- What is Competitive Landscape of LeMaitre Vascular Company?
- What is Growth Strategy and Future Prospects of LeMaitre Vascular Company?
- How Does LeMaitre Vascular Company Work?
- What is Sales and Marketing Strategy of LeMaitre Vascular Company?
- What are Mission Vision & Core Values of LeMaitre Vascular Company?
- What is Customer Demographics and Target Market of LeMaitre Vascular Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.